{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:53:00Z","timestamp":1790779980384,"version":"4.1.0"},"reference-count":94,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":165,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["326000-121314\/1"],"award-info":[{"award-number":["326000-121314\/1"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["3100A0-109981"],"award-info":[{"award-number":["3100A0-109981"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007393","name":"Association Fran\u00e7aise contre les Myopathies","doi-asserted-by":"publisher","award":["13091"],"award-info":[{"award-number":["13091"]}],"id":[{"id":"10.13039\/100007393","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007393","name":"Association Fran\u00e7aise contre les Myopathies","doi-asserted-by":"publisher","award":["13984"],"award-info":[{"award-number":["13984"]}],"id":[{"id":"10.13039\/100007393","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007393","name":"Association Fran\u00e7aise contre les Myopathies","doi-asserted-by":"publisher","award":["13090"],"award-info":[{"award-number":["13090"]}],"id":[{"id":"10.13039\/100007393","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007393","name":"Association Fran\u00e7aise contre les Myopathies","doi-asserted-by":"publisher","award":["15093"],"award-info":[{"award-number":["15093"]}],"id":[{"id":"10.13039\/100007393","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.ajpath.2012.10.018","type":"journal-article","created":{"date-parts":[[2013,1,15]],"date-time":"2013-01-15T23:15:12Z","timestamp":1358291712000},"page":"485-504","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":110,"title":["The Anticancer Drug Tamoxifen Counteracts the Pathology in a Mouse Model of Duchenne Muscular Dystrophy"],"prefix":"10.1016","volume":"182","author":[{"given":"Olivier M.","family":"Dorchies","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Reutenauer-Patte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elyes","family":"Dahmane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hesham M.","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Petermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oph\u00e9lie","family":"Patthey-Vuadens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie A.","family":"Comyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elinam","family":"Gayi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Piacenza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Handa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent A.","family":"D\u00e9costerd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urs T.","family":"Ruegg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2012.10.018_bib1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/B978-0-08-045031-5.00002-5","article-title":"Dystrophinopathies","volume":"101","author":"Morrison","year":"2011","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.ajpath.2012.10.018_bib2","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1440-1681.2006.04394.x","article-title":"Muscle damage in mdx (dystrophic) mice: role of calcium and reactive oxygen species","volume":"33","author":"Whitehead","year":"2006","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.ajpath.2012.10.018_bib3","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1139\/Y09-058","article-title":"Calcium and the damage pathways in muscular dystrophy","volume":"88","author":"Allen","year":"2010","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.ajpath.2012.10.018_bib4","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/mus.22097","article-title":"Cardiomyopathy of Duchenne muscular dystrophy: current understanding and future directions","volume":"44","author":"Spurney","year":"2011","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ajpath.2012.10.018_bib5","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2165\/11594070-000000000-00000","article-title":"Pathophysiology and therapy of cardiac dysfunction in Duchenne muscular dystrophy","volume":"11","author":"Judge","year":"2011","journal-title":"Am J Cardiovasc Drugs"},{"issue":"1","key":"10.1016\/j.ajpath.2012.10.018_bib6","first-page":"CD003725","article-title":"Glucocorticoid corticosteroids for Duchenne muscular dystrophy","author":"Manzur","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajpath.2012.10.018_bib7","doi-asserted-by":"crossref","first-page":"206","DOI":"10.2174\/156652312800840595","article-title":"Pharmacologically targeting the primary defect and downstream pathology in Duchenne muscular dystrophy","volume":"12","author":"Fairclough","year":"2012","journal-title":"Curr Gene Ther"},{"key":"10.1016\/j.ajpath.2012.10.018_bib8","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/WCO.0b013e328357b0be","article-title":"Gene therapy for Duchenne muscular dystrophy","volume":"25","author":"Verhaart","year":"2012","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.ajpath.2012.10.018_bib9","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0960-0760(03)00059-1","article-title":"Aromatase in skeletal muscle","volume":"84","author":"Larionov","year":"2003","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.ajpath.2012.10.018_bib10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00418-005-0030-z","article-title":"Oestrogen receptor beta is present in both muscle fibres and endothelial cells within human skeletal muscle tissue","volume":"124","author":"Wiik","year":"2005","journal-title":"Histochem Cell Biol"},{"key":"10.1016\/j.ajpath.2012.10.018_bib11","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00418-006-0224-z","article-title":"Evidence for estrogen receptor alpha and beta expression in skeletal muscle of pigs","volume":"127","author":"Kalbe","year":"2006","journal-title":"Histochem Cell Biol"},{"issue":"Pt 1","key":"10.1016\/j.ajpath.2012.10.018_bib12","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1113\/jphysiol.1996.sp021381","article-title":"Changes in muscle strength, relaxation rate and fatiguability during the human menstrual cycle","volume":"493","author":"Sarwar","year":"1996","journal-title":"J\u00a0Physiol (Lond)"},{"key":"10.1016\/j.ajpath.2012.10.018_bib13","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1152\/japplphysiol.01583.2005","article-title":"Estrogen status and skeletal muscle recovery from disuse atrophy","volume":"100","author":"McClung","year":"2006","journal-title":"J\u00a0Appl Physiol"},{"key":"10.1016\/j.ajpath.2012.10.018_bib14","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/0960-0760(91)90292-D","article-title":"Tamoxifen and oestrogen both protect the rat muscle against physiological damage","volume":"40","author":"Koot","year":"1991","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"key":"10.1016\/j.ajpath.2012.10.018_bib15","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/GCO.0b013e3283488a21","article-title":"Cardiovascular disease and ovarian function","volume":"23","author":"Kallen","year":"2011","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.ajpath.2012.10.018_bib16","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/MNH.0b013e3283431921","article-title":"Estrogen, hormonal replacement therapy and cardiovascular disease","volume":"20","author":"Yang","year":"2011","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.ajpath.2012.10.018_bib17","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1001\/jama.295.23.joc60074","article-title":"Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes","volume":"295","author":"Vogel","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.ajpath.2012.10.018_bib18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1586\/14737140.9.1.51","article-title":"The NSABP Study of Tamoxifen and Raloxifene (STAR) trial","volume":"9","author":"Vogel","year":"2008","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.ajpath.2012.10.018_bib19","first-page":"RA144","article-title":"The multiple applications of tamoxifen: an example pointing to SERM modulation being the aspirin of the 21st century","volume":"14","author":"Singh","year":"2008","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.ajpath.2012.10.018_bib20","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/0006-2952(94)90073-6","article-title":"Tamoxifen and hydroxytamoxifen as intramembraneous inhibitors of lipid peroxidation. Evidence for peroxyl radical scavenging activity","volume":"47","author":"Custodio","year":"1994","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.ajpath.2012.10.018_bib21","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1006\/taap.1998.8510","article-title":"Tamoxifen inhibits induction of the mitochondrial permeability transition by Ca2+ and inorganic phosphate","volume":"152","author":"Custodio","year":"1998","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.ajpath.2012.10.018_bib22","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1006\/jsre.2001.6350","article-title":"Tamoxifen decreases fibroblast function and downregulates TGF\u03b22 in Dupuytren\u2019s affected palmar fascia","volume":"103","author":"Kuhn","year":"2002","journal-title":"J Surg Res"},{"key":"10.1016\/j.ajpath.2012.10.018_bib23","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/01.sap.0000199155.73000.2f","article-title":"Down-regulating causes of fibrosis with tamoxifen: a possible cellular\/molecular approach to treat rhinophyma","volume":"56","author":"Payne","year":"2006","journal-title":"Ann Plast Surg"},{"key":"10.1016\/j.ajpath.2012.10.018_bib24","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1038\/sj.bjp.0703924","article-title":"Effects of anti-oestrogens and beta-estradiol on calcium uptake by cardiac sarcoplasmic reticulum","volume":"132","author":"Dodds","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ajpath.2012.10.018_bib25","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/sj.bjp.0706265","article-title":"Modulation of mitochondrial Ca2+ uptake by estrogen receptor agonists and antagonists","volume":"145","author":"Lobat\u00f3n","year":"2005","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ajpath.2012.10.018_bib26","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1158\/1541-7786.MCR-09-0188","article-title":"Tamoxifen inhibits TRPV6 activity via estrogen receptor\u2013independent pathways in TRPV6-expressing MCF-7 breast cancer cells","volume":"7","author":"Bolanz","year":"2009","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.ajpath.2012.10.018_bib27","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/cne.21490","article-title":"Detection and localization of an estrogen receptor beta splice variant protein (ERbeta2) in the adult female rat forebrain and midbrain regions","volume":"505","author":"Chung","year":"2007","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.ajpath.2012.10.018_bib28","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1152\/physrev.00026.2006","article-title":"Estrogen receptors: how do they signal and what are their targets","volume":"87","author":"Heldring","year":"2007","journal-title":"Physiol Rev"},{"key":"10.1016\/j.ajpath.2012.10.018_bib29","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.nmd.2009.05.003","article-title":"Developing standard procedures for murine and canine efficacy studies of DMD therapeutics: report of two expert workshops on \u201cPre-clinical testing for Duchenne dystrophy\u201d: Washington DC, October 27th-28th 2007 and Z\u00fcrich, June 30th-July 1st 2008","volume":"19","author":"Nagaraju","year":"2009","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.ajpath.2012.10.018_bib30","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1016\/j.ajpath.2011.07.009","article-title":"mdx5cv mice manifest more severe muscle dysfunction and diaphragm force deficits than do mdx mice","volume":"179","author":"Beastrom","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2012.10.018_bib31","doi-asserted-by":"crossref","first-page":"C616","DOI":"10.1152\/ajpcell.00425.2005","article-title":"Green tea extract and its major polyphenol (-)-epigallocatechin gallate improve muscle function in a mouse model for Duchenne muscular dystrophy","volume":"290","author":"Dorchies","year":"2006","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.ajpath.2012.10.018_bib32","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/mt.2008.239","article-title":"Gene-mediated restoration of normal myofiber elasticity in dystrophic muscles","volume":"17","author":"Puttini","year":"2009","journal-title":"Mol Ther"},{"key":"10.1016\/j.ajpath.2012.10.018_bib33","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1600-079X.2011.00871.x","article-title":"Melatonin improves muscle function of the dystrophic mdx5Cv mouse, a model for Duchenne muscular dystrophy","volume":"51","author":"Hibaoui","year":"2011","journal-title":"J Pineal Res"},{"key":"10.1016\/j.ajpath.2012.10.018_bib34","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.ajpath.2011.10.038","article-title":"Urocortins improve dystrophic skeletal muscle structure and function through both PKA- and Epac-dependent pathways","volume":"180","author":"Reutenauer-Patte","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2012.10.018_bib35","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/bjp.2008.285","article-title":"Investigation of Debio 025, a cyclophilin inhibitor, in the dystrophic mdx mouse, a model for Duchenne muscular dystrophy","volume":"155","author":"Reutenauer","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ajpath.2012.10.018_bib36","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00418-012-0926-3","article-title":"Quantitative evaluation of the beneficial effects in the mdx mouse of epigallocatechin gallate, an antioxidant polyphenol from green tea","volume":"137","author":"Nakae","year":"2012","journal-title":"Histochem Cell Biol"},{"key":"10.1016\/j.ajpath.2012.10.018_bib37","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1016\/j.jchromb.2010.10.027","article-title":"An ultra performance liquid chromatography\u2013tandem MS assay for tamoxifen metabolites profiling in plasma: first evidence of 4\u2032-hydroxylated metabolites in breast cancer patients","volume":"878","author":"Dahmane","year":"2010","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.ajpath.2012.10.018_bib38","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.nmd.2004.06.008","article-title":"Histological parameters for the quantitative assessment of muscular dystrophy in the mdx-mouse","volume":"14","author":"Briguet","year":"2004","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.ajpath.2012.10.018_bib39","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0303-7207(98)00050-1","article-title":"Estrogen receptor-\u03b2 mRNA variants in human and murine tissues","volume":"138","author":"Lu","year":"1998","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.ajpath.2012.10.018_bib40","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jneumeth.2009.11.006","article-title":"A simple protocol for assessing inter-trial and inter-examiner reliability for two noninvasive measures of limb muscle strength","volume":"186","author":"Carlson","year":"2010","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.ajpath.2012.10.018_bib41","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/FTD.0b013e318067ded7","article-title":"Tamoxifen and its main metabolites serum and tissue concentrations in breast cancer women","volume":"29","author":"Furlanut","year":"2007","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.ajpath.2012.10.018_bib42","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/clpt.2011.32","article-title":"Tamoxifen metabolite concentrations. CYP2D6 genotype, and breast cancer outcomes","volume":"89","author":"Madlensky","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ajpath.2012.10.018_bib43","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0090-9556(25)07102-8","article-title":"Metabolites, pharmacodynamics, and pharmacokinetics of tamoxifen in rats and mice compared to the breast cancer patient","volume":"19","author":"Robinson","year":"1991","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.ajpath.2012.10.018_bib44","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/clpt.2011.27","article-title":"Activity levels of tamoxifen metabolites at the estrogen receptor and the impact of genetic polymorphisms of phase I and II enzymes on their concentration levels in plasma","volume":"89","author":"Murdter","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ajpath.2012.10.018_bib45","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0022-3476(03)00128-8","article-title":"Tamoxifen treatment for precocious puberty in McCune-Albright syndrome: a multicenter trial","volume":"143","author":"Eugster","year":"2003","journal-title":"J Pediatr"},{"key":"10.1016\/j.ajpath.2012.10.018_bib46","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S1567-7249(02)00034-X","article-title":"4-Hydroxytamoxifen is a potent inhibitor of the mitochondrial permeability transition","volume":"1","author":"Cardoso","year":"2002","journal-title":"Mitochondrion"},{"key":"10.1016\/j.ajpath.2012.10.018_bib47","doi-asserted-by":"crossref","first-page":"101","DOI":"10.7326\/0003-4819-144-2-200601170-00007","article-title":"Brief communication: tamoxifen therapy for nonmalignant retroperitoneal fibrosis","volume":"144","author":"van Bommel","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajpath.2012.10.018_bib48","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1093\/hmg\/ddn408","article-title":"Dominant-negative inhibition of Ca2+ influx via TRPV2 ameliorates muscular dystrophy in animal models","volume":"18","author":"Iwata","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ajpath.2012.10.018_bib49","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1172\/JCI43844","article-title":"Mitigation of muscular dystrophy in mice by SERCA overexpression in skeletal muscle","volume":"121","author":"Goonasekera","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2012.10.018_bib50","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/1074248410381757","article-title":"Losartan decreases cardiac muscle fibrosis and improves cardiac function in dystrophin-deficient mdx mice","volume":"16","author":"Spurney","year":"2011","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.ajpath.2012.10.018_bib51","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00418-008-0390-2","article-title":"Subcutaneous injection, from birth, of epigallocatechin-3-gallate, a component of green tea, limits the onset of muscular dystrophy in mdx mice: a quantitative histological, immunohistochemical and electrophysiological study","volume":"129","author":"Nakae","year":"2008","journal-title":"Histochem Cell Biol"},{"key":"10.1016\/j.ajpath.2012.10.018_bib52","first-page":"4837","article-title":"Distribution of tamoxifen and its metabolites in rat and human tissues during steady-state treatment","volume":"51","author":"Lien","year":"1991","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2012.10.018_bib53","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1021\/ci2001082","article-title":"A mechanistic hypothesis for the cytochrome P450-catalyzed cis\u2013trans isomerization of 4-hydroxytamoxifen: an unusual redox reaction","volume":"51","author":"Gao","year":"2011","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.ajpath.2012.10.018_bib54","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1023\/B:JURE.0000021398.78327.39","article-title":"Effects of ovariectomy and estrogen on skeletal muscle function in growing rats","volume":"25","author":"McCormick","year":"2004","journal-title":"J Muscle Res Cell Motil"},{"key":"10.1016\/j.ajpath.2012.10.018_bib55","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1113\/expphysiol.2004.028373","article-title":"Effect of oestrogen on myofibre size and myosin expression in growing rats","volume":"90","author":"Piccone","year":"2005","journal-title":"Exp Physiol"},{"key":"10.1016\/j.ajpath.2012.10.018_bib56","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1152\/jappl.2001.90.2.724","article-title":"Invited Review: redox modulation of skeletal muscle contraction: what we know and what we don\u2019t","volume":"90","author":"Reid","year":"2001","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.ajpath.2012.10.018_bib57","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1139\/h03-058","article-title":"Regulation of blood flow at the onset of exercise by feed forward and feedback mechanisms","volume":"28","author":"Hughson","year":"2003","journal-title":"Can J Appl Physiol"},{"key":"10.1016\/j.ajpath.2012.10.018_bib58","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1139\/h2012-016","article-title":"Should postactivation potentiation be the goal of your warm-up?","volume":"37","author":"Macintosh","year":"2012","journal-title":"Appl Physiol Nutr Metab"},{"key":"10.1016\/j.ajpath.2012.10.018_bib59","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.coph.2012.03.007","article-title":"The sarcomeric cytoskeleton as a target for pharmacological intervention","volume":"12","author":"Kho","year":"2012","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.ajpath.2012.10.018_bib60","series-title":"International Review of Cell and Molecular Biology","first-page":"67","article-title":"Calcineurin signaling and the slow oxidative skeletal muscle fiber type. ch 2","author":"Mallinson","year":"2009"},{"key":"10.1016\/j.ajpath.2012.10.018_bib61","doi-asserted-by":"crossref","first-page":"E8","DOI":"10.1152\/ajpendo.00403.2009","article-title":"Constitutively active calcineurin in skeletal muscle increases endurance performance and mitochondrial respiratory capacity","volume":"298","author":"Jiang","year":"2010","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.ajpath.2012.10.018_bib62","doi-asserted-by":"crossref","first-page":"721219","DOI":"10.1155\/2010\/721219","article-title":"The functional role of calcineurin in hypertrophy, regeneration, and disorders of skeletal muscle","volume":"2010","author":"Sakuma","year":"2010","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.ajpath.2012.10.018_bib63","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1113\/jphysiol.2006.108472","article-title":"Activated calcineurin ameliorates contraction-induced injury to skeletal muscles of mdx dystrophic mice","volume":"575","author":"Stupka","year":"2006","journal-title":"J Physiol"},{"key":"10.1016\/j.ajpath.2012.10.018_bib64","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/0092-8674(88)90463-1","article-title":"Fast muscle fibers are preferentially affected in Duchenne muscular dystrophy","volume":"52","author":"Webster","year":"1988","journal-title":"Cell"},{"key":"10.1016\/j.ajpath.2012.10.018_bib65","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/BF00121296","article-title":"Increased susceptibility of EDL muscles from mdx mice to damage induced by contractions with stretch","volume":"14","author":"Moens","year":"1993","journal-title":"J Muscle Res Cell Motil"},{"key":"10.1016\/j.ajpath.2012.10.018_bib66","doi-asserted-by":"crossref","first-page":"7791","DOI":"10.1073\/pnas.0932671100","article-title":"Expression of utrophin A mRNA correlates with the oxidative capacity of skeletal muscle fiber types and is regulated by calcineurin\/NFAT signaling","volume":"100","author":"Chakkalakal","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2012.10.018_bib67","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1023\/A:1010305801236","article-title":"Comparative evolution of muscular dystrophy in diaphragm, gastrocnemius and masseter muscles from old male mdx mice","volume":"22","author":"Muller","year":"2001","journal-title":"J Muscle Res Cell Motil"},{"key":"10.1016\/j.ajpath.2012.10.018_bib68","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1152\/physrev.2000.80.3.1215","article-title":"Calcium ion in skeletal muscle: its crucial role for muscle function, plasticity, and disease","volume":"80","author":"Berchtold","year":"2000","journal-title":"Physiol Rev"},{"key":"10.1016\/j.ajpath.2012.10.018_bib69","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s10974-006-9076-3","article-title":"RyR isoforms and fibre type-specific expression of proteins controlling intracellular calcium concentration in skeletal muscles","volume":"27","author":"Reggiani","year":"2006","journal-title":"J Muscle Res Cell Motil"},{"key":"10.1016\/j.ajpath.2012.10.018_bib70","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-201X.2005.01450.x","article-title":"Effect of cyclopiazonic acid, an inhibitor of the sarcoplasmic reticulum Ca-ATPase, on skeletal muscles from normal and mdx mice","volume":"184","author":"Divet","year":"2005","journal-title":"Acta Physiol Scand"},{"key":"10.1016\/j.ajpath.2012.10.018_bib71","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1016\/S0960-8966(02)00087-1","article-title":"The role of utrophin in the potential therapy of\u00a0Duchenne muscular dystrophy","volume":"12","author":"Perkins","year":"2002","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.ajpath.2012.10.018_bib72","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0002-9440(10)62249-3","article-title":"Transgenic expression of \u03b17\u03b21 integrin maintains muscle integrity, increases regenerative capacity, promotes hypertrophy, and reduces cardiomyopathy in dystrophic mice","volume":"166","author":"Burkin","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2012.10.018_bib73","doi-asserted-by":"crossref","first-page":"C228","DOI":"10.1152\/ajpcell.00266.2011","article-title":"Absolute amounts and diffusibility of HSP72. HSP25, and \u03b1B-crystallin in fast- and slow-twitch skeletal muscle fibers of rat","volume":"302","author":"Larkins","year":"2012","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.ajpath.2012.10.018_bib74","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1248\/bpb.34.1653","article-title":"Molecular mechanisms of alpha-crystallinopathy and its therapeutic strategy","volume":"34","author":"Sanbe","year":"2011","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.ajpath.2012.10.018_bib75","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.bpj.2009.11.005","article-title":"Microarchitecture is severely compromised but motor protein function is preserved in dystrophic mdx skeletal muscle","volume":"98","author":"Friedrich","year":"2010","journal-title":"Biophys J"},{"key":"10.1016\/j.ajpath.2012.10.018_bib76","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1152\/japplphysiol.00803.2009","article-title":"Eccentric contractions lead to myofibrillar dysfunction in muscular dystrophy","volume":"108","author":"Blaauw","year":"2010","journal-title":"J\u00a0Appl Physiol"},{"key":"10.1016\/j.ajpath.2012.10.018_bib77","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1113\/expphysiol.2009.052019","article-title":"Branched fibres in old dystrophic mdx muscle are associated with mechanical weakening of the sarcolemma, abnormal Ca2+ transients and a breakdown of Ca2+ homeostasis during fatigue","volume":"95","author":"Head","year":"2010","journal-title":"Exp Physiol"},{"key":"10.1016\/j.ajpath.2012.10.018_bib78","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1055\/s-2008-1025894","article-title":"Steroid receptors in two types of rabbit skeletal muscle","volume":"5","author":"Saartok","year":"1984","journal-title":"Int J Sports Med"},{"key":"10.1016\/j.ajpath.2012.10.018_bib79","article-title":"Hormonal receptors in skeletal muscles of dystrophic mice","author":"Feder","year":"2012","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.ajpath.2012.10.018_bib80","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/00000637-199805000-00008","article-title":"Tamoxifen downregulates TGF-beta production in keloid fibroblasts","volume":"40","author":"Chau","year":"1998","journal-title":"Ann Plast Surg"},{"key":"10.1016\/j.ajpath.2012.10.018_bib81","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/352536a0","article-title":"The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy","volume":"352","author":"Stedman","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2012.10.018_bib82","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1249\/01.MSS.0000106185.22349.2C","article-title":"Targeting the immune system to improve ventilatory function in muscular dystrophy","volume":"36","author":"Gosselin","year":"2004","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.ajpath.2012.10.018_bib83","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/mus.21869","article-title":"Prevention of muscle fibrosis and myonecrosis in mdx mice by suramin, a TGF-\u03b21 blocker","volume":"43","author":"Taniguti","year":"2011","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ajpath.2012.10.018_bib84","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0005-2736(93)90080-J","article-title":"The anticancer drug tamoxifen induces changes in the physical properties of model and native membranes","volume":"1150","author":"Custodio","year":"1993","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ajpath.2012.10.018_bib85","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1210\/en.2008-0133","article-title":"Estrogen inhibits cardiac hypertrophy: role of estrogen receptor-\u03b2 to inhibit calcineurin","volume":"149","author":"Pedram","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.ajpath.2012.10.018_bib86","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1210\/me.2010-0154","article-title":"Estrogen receptor-\u03b2 prevents cardiac fibrosis","volume":"24","author":"Pedram","year":"2010","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.ajpath.2012.10.018_bib87","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.tem.2004.01.008","article-title":"Anatomy of the estrogen response element","volume":"15","author":"Gruber","year":"2004","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.ajpath.2012.10.018_bib88","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1172\/JCI117514","article-title":"Tamoxifen blocks chloride channels. A possible mechanism for cataract formation","volume":"94","author":"Zhang","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2012.10.018_bib89","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/sj.clpt.6100367","article-title":"Tamoxifen pharmacogenomics: the role of CYP2D6 as a predictor of drug response","volume":"83","author":"Goetz","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ajpath.2012.10.018_bib90","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1517\/14656560903200634","article-title":"Pharmacologic treatment of male breast cancer","volume":"10","author":"Hayes","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.ajpath.2012.10.018_bib91","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1515\/JPEM.2008.21.5.449","article-title":"Long-term follow-up of tamoxifen treatment in adolescents with gynecomastia","volume":"21","author":"Derman","year":"2008","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.ajpath.2012.10.018_bib92","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1542\/peds.2005-0577","article-title":"The use of tamoxifen to improve height potential in short pubertal boys","volume":"116","author":"Kreher","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajpath.2012.10.018_bib93","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.nmd.2011.02.006","article-title":"Endocrine aspects of Duchenne muscular dystrophy","volume":"21","author":"Bianchi","year":"2011","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.ajpath.2012.10.018_bib94","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/dvg.20294","article-title":"Increased bone mass in male and female mice following tamoxifen administration","volume":"45","author":"Starnes","year":"2007","journal-title":"Genesis"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944012008127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944012008127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T11:02:00Z","timestamp":1762081320000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944012008127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":94,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S0002944012008127"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2012.10.018","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Anticancer Drug Tamoxifen Counteracts the Pathology in a Mouse Model of Duchenne Muscular Dystrophy","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2012.10.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}